Krystal Biotech, Inc.
DE ˙ DB ˙ US5011471027
257,90 € ↓ -1,10 (-0,42%)
2026-06-04
AKTIENPREIS
SecurityDE:4KB / Krystal Biotech, Inc.
InstitutionNorthern Trust Corp
Latest Disclosed Ownership252,463 shares
Latest Disclosed Value $ 65,216,242
Northern Trust Corp reports 2.03% increase in ownership of 4KB / Krystal Biotech, Inc.

On May 14, 2026 - Northern Trust Corp filed a 13F-HR form disclosing ownership of 252,463 shares of Krystal Biotech, Inc. (DE:4KB) valued at $54,330,038 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 247,443 shares of Krystal Biotech, Inc.. This represents a change in shares of 2.03% during the quarter. The current value of the position is $65,110,208 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F KRYSTAL BIOTECH COM 501147102 252,463 5,020 2.03 65,216 6.90 0.0018
2026-02-17 2025-12-31 13F KRYSTAL BIOTECH COM 501147102 247,443 -722 -0.29 61,005 39.25 0.0016
2025-11-14 2025-09-30 13F KRYSTAL BIOTECH COM 501147102 248,165 -3,243 -1.29 43,809 26.77 0.0013
2025-08-13 2025-06-30 13F KRYSTAL BIOTECH COM 501147102 251,408 -8,587 -3.30 34,559 -26.28 0.0048
2025-05-13 2025-03-31 13F KRYSTAL BIOTECH COM 501147102 259,995 -2,268 -0.86 46,877 14.09 0.0070
2025-02-14 2024-12-31 13F KRYSTAL BIOTECH COM 501147102 262,263 23,572 9.88 41,086 -5.44 0.0058
2024-11-13 2024-09-30 13F KRYSTAL BIOTECH COM 501147102 238,691 20,230 9.26 43,449 8.30 0.0071
2024-08-14 2024-06-30 13F KRYSTAL BIOTECH COM 501147102 218,461 13,383 6.53 40,118 9.95 0.0068
2024-05-14 2024-03-31 13F KRYSTAL BIOTECH COM 501147102 205,078 -4,121 -1.97 36,490 40.60 0.0063
2024-02-13 2023-12-31 13F KRYSTAL BIOTECH COM 501147102 209,199 -4,064 -1.91 25,953 4.91 0.0047
2023-11-13 2023-09-30 13F KRYSTAL BIOTECH COM 501147102 213,263 4,129 1.97 24,739 0.76 0.0048
2023-08-11 2023-06-30 13F KRYSTAL BIOTECH COM 501147102 209,134 7,657 3.80 24,552 52.21 0.0047
2023-05-15 2023-03-31 13F KRYSTAL BIOTECH COM 501147102 201,477 189 0.09 16,130 1.15 0.0032
2023-02-13 2022-12-31 13F KRYSTAL BIOTECH COM 501147102 201,288 -950 -0.47 15,946 13.12 0.0033
2022-11-14 2022-09-30 13F KRYSTAL BIOTECH COM 501147102 202,238 1,180 0.59 14,097 6.79 0.0032
2022-08-12 2022-06-30 13F KRYSTAL BIOTECH COM 501147102 201,058 6,956 3.58 13,201 2.21 0.0028
2022-05-13 2022-03-31 13F KRYSTAL BIOTECH COM 501147102 194,102 10,543 5.74 12,915 0.58 0.0023
2022-02-08 2021-12-31 13F KRYSTAL BIOTECH COM 501147102 183,559 2,125 1.17 12,840 35.54 0.0021
2021-11-15 2021-09-30 13F KRYSTAL BIOTECH COM 501147102 181,434 -7,121 -3.78 9,473 -26.12 0.0017
2021-08-13 2021-06-30 13F KRYSTAL BIOTECH COM 501147102 188,555 9,913 5.55 12,822 -6.83 0.0023
2021-05-12 2021-03-31 13F KRYSTAL BIOTECH COM 501147102 178,642 5,516 3.19 13,762 32.48 0.0026
2021-02-11 2020-12-31 13F KRYSTAL BIOTECH COM 501147102 173,126 -4,298 -2.42 10,388 35.99 0.0020
2020-11-16 2020-09-30 13F KRYSTAL BIOTECH COM 501147102 177,424 12,416 7.52 7,639 11.76 0.0017
2020-08-14 2020-06-30 13F KRYSTAL BIOTECH COM 501147102 165,008 16,369 11.01 6,835 6.35 0.0016
2020-05-14 2020-03-31 13F KRYSTAL BIOTECH COM 501147102 148,639 9,045 6.48 6,427 -16.86 0.0018
2020-02-14 2019-12-31 13F KRYSTAL BIOTECH COM 501147102 139,594 -3,455 -2.42 7,730 55.63 0.0017
2019-11-13 2019-09-30 13F KRYSTAL BIOTECH COM 501147102 143,049 103,065 257.77 4,967 208.70 0.0012
2019-08-13 2019-06-30 13F KRYSTAL BIOTECH COM 501147102 39,984 18,560 86.63 1,609 128.23 0.0004
2019-05-13 2019-03-31 13F KRYSTAL BIOTECH COM 501147102 21,424 -421 -1.93 705 55.29 0.0002
2019-02-12 2018-12-31 13F KRYSTAL BIOTECH COM 501147102 21,845 21,845 454 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.